Research
Energy balance
Pharmacists can effectively evaluate and monitor the use of GLP-1 therapy in weight management patients.
Utilizing pharmacists in weight management can enhance patient care and therapy outcomes.
StrongSupportsmedium confidence
Pharmacists possess the accessibility and extensive medication knowledge to evaluate and monitor the use of GLP-1 therapy in weight management patients.
Why this rating
The study is a retrospective cohort study with a clear focus on pharmacist involvement.
Source
Evaluation of a pharmacist’s impact on the use of glucagon-like peptide-1 receptor agonists for weight management in a family medicine setting
Nicholas Crocetta et al. · Family Practice · 2022
DOI 10.1093/fampra/cmac110
cohort · n=85Cited 9×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Patients in the clinical pharmacist cohort achieved a mean body weight reduction of 9.32% compared to 5.11% body weight reduction for patients in the primary care physician cohort.Strong
- The implementation of a pharmacist-led weight management clinic resulted in an estimated cost savings of $101,985.66.Strong
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →